In July 2020, remimazolam besylate (brand name: Byfavo) was approved with the FDA to the induction and maintenance of procedural sedation in Older people undergoing strategies Long lasting 30 minutes or less. Triflubazam is similar to clobazam in terms of effects. It had been researched in the 1970s as a potential anxiolytic and sedative but